Economy/Home · Economy

[IPO Preview] MS Bio Sets Offer Price at 7,800 Won with Demand Forecast Competition Ratio of 1,096.56 to 1… Subscription Oct 12–13, KOSDAQ Listing Oct 22

MS Bio is opening its public subscription ahead of its listing on the KOSDAQ market. The offering price for the company, which produces medical human tissue implants and biomaterial-based medical devices, has been set at 7,800 won per share. ■ Subscription and Listing Schedule The general public su

Wooil Shim
Staff Reporter
5 min read
[IPO Preview] MS Bio Sets Offer Price at 7,800 Won with Demand Forecast Competition Ratio of 1,096.56 to 1… Subscription Oct 12–13, KOSDAQ Listing Oct 22
CBC News

MS Bio is opening its public subscription ahead of its listing on the KOSDAQ market. The offering price for the company, which produces medical human tissue implants and biomaterial-based medical devices, has been set at 7,800 won per share.

■ Subscription and Listing Schedule The general public subscription will run for two days from October 12 to 13, with KB Securities as the underwriter. The listing date is scheduled for October 22. The number of shares offered is 4 million, and the total offering size based on the offer price is 31.2 billion won. The number of shares to be listed is 27,202,650, and the market capitalization based on the offer price is approximately 212.2 billion won.

■ Demand Forecast and Listing Timeline The institutional demand forecast competition ratio recorded 1,096.56 to 1. The listing timeline was presented as follows: a preliminary listing review application on April 16, approval on July 10, and a demand forecast conducted from September 28 to October 2. After the general subscription, the company is scheduled to list on the KOSDAQ market on October 22.

■ Company Overview MS Bio is a medical device manufacturer founded on October 27, 2015. Its main products are medical human tissue implants and biomaterial-based medical devices, and its headquarters is located in Seongnam, Gyeonggi Province. The CEO and largest shareholder is Kim Seong-po, and the number of employees stated in the corporate profile is 53.

■ Financial Status Revenue was 23.787 billion won, operating profit before corporate tax deduction from continuing operations was 8.595 billion won, and net income was 7.288 billion won. Equity capital stands at 28.996 billion won. However, these figures should be compared after confirming the fiscal year to which they pertain.

■ Investor Cautions The institutional demand forecast competition ratio and the general subscription competition ratio are different indicators. Investors considering subscription should review, along with institutional participation results, the business risks stated in the securities registration statement, the plan for using the offering proceeds, and the volume of shares available for circulation after listing.

[This article is an informational piece based on publicly available corporate and offering information and is not an investment solicitation. Subscription and listing schedules and offering terms are subject to change, so final details must be confirmed through the securities registration statement and the lead underwriter's announcements. IPO investments carry the risk of principal loss, and investment decisions and responsibilities rest with the investor. AI assistance was used in writing this article.]

Wooil Shim
Staff Reporter

CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.